tag:blogger.com,1999:blog-16195928069796593942024-03-21T22:33:25.672-05:00Medical TidbitsHighlights Of The Latest Medical NewsAnonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.comBlogger1571125tag:blogger.com,1999:blog-1619592806979659394.post-49695613495555853062016-06-15T17:39:00.001-05:002016-06-15T17:39:11.553-05:00FDA Strengthens Warning On Labels Of Two Diabetes Medications To
Reflect Risk Of Acute Kidney Injuries.<div style="text-align: start;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016061501tma&r=7000424-a81c&l=016-1bf&t=c" style="text-align: justify;">MedPage Today</a><span style="text-align: justify;"> (6/14, Brown) reports that “the FDA is strengthening a warning on the labels of two diabetes drugs to reflect risk of acute kidney injuries.” The “new labels for the two sodium-glucose transport 2 (SGLT-2) drugs – canagliflozin (Invokana) and dapagliflozin (Farxiga) – will have more information about acute kidney injuries and add recommendations about how to minimize risk, said the FDA on its website” yesterday. The FDA “says that the strengthened warning comes after they have received reports of 101 confirmable cases of acute kidney injury from March of 2013 to October of” last year.</span></span></font></div><div style="text-align: start;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="text-align: justify;"><br></span></span></font></div><div style="text-align: start;">http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm506554.htm</div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com1tag:blogger.com,1999:blog-1619592806979659394.post-87147289396210499292016-04-15T13:46:00.001-05:002016-04-15T13:46:55.092-05:00PPIs May Be Linked To An Increased Risk Of CKD.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEbvSNJEiVaGeYq-QkOlgOifLjNB8EXOhSaqO_45TDN6ymhnlHOoykbyyM5-Yh8XS_a4u4bBmqg3yTNoyUXhPHqEwX0Ub8XrbK-JM9y4G5Q4yKSZToR0BV3VnWRDWyWluigJ6hyphenhyphenGz3T7aB/s640/blogger-image--16282369.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhEbvSNJEiVaGeYq-QkOlgOifLjNB8EXOhSaqO_45TDN6ymhnlHOoykbyyM5-Yh8XS_a4u4bBmqg3yTNoyUXhPHqEwX0Ub8XrbK-JM9y4G5Q4yKSZToR0BV3VnWRDWyWluigJ6hyphenhyphenGz3T7aB/s640/blogger-image--16282369.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><u>ABC World News Tonight</u> (4/14, story 10, <a dir="ltr" href="x-apple-data-detectors://18" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="18">0:25</a>, Muir) reported that a study has linked “proton pump inhibitors including Nexium [esomeprazole magnesium] and Prilosec [omeprazole] to an increased risk of chronic kidney disease [CKD].”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">According to <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016041501tma&r=7000424-1338&l=013-958&t=c">CNN</a> (4/14, Christensen), some “173,321 people who used PPIs and 20,270” who “took a PPI alternative known as histamine H2 receptor blockers” were included in the five-year study.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016041501tma&r=7000424-1338&l=014-b99&t=c">CBS News</a> (4/14, Welch) website reports that “over five years of follow-up...15 percent of people using PPIs were diagnosed with chronic kidney disease, versus 11 percent of those on H2-blockers,” which “translated to a 28 percent increased risk of developing kidney disease for PPI users.” While just “a few patients in the study – less than 0.2 percent – developed end-stage kidney failure..the risk was 96 percent higher for those on PPIs.” The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016041501tma&r=7000424-1338&l=015-fe9&t=c">study</a> was published online in the Journal of the American Society of Nephrology.</span></p></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com1tag:blogger.com,1999:blog-1619592806979659394.post-759009178907313552016-03-10T08:25:00.001-06:002016-03-10T08:25:09.677-06:00Ultra-Processed Foods Now Make Up 58% Of All Calories Americans Consume
In A Typical Day, Study Finds.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8qTnBarCbsdzev8zL0Z36KNiVZwjT65BT35SQnTl8TyQvGJxokKXpfgzO4kPAFbgAv6fCyfSXE4e76CZlz744aePNQVkp9NSQsoKpJLDYuf08406V-hyfAfBP7s-xroPtAs1wMsEVnp1L/s640/blogger-image--131357088.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8qTnBarCbsdzev8zL0Z36KNiVZwjT65BT35SQnTl8TyQvGJxokKXpfgzO4kPAFbgAv6fCyfSXE4e76CZlz744aePNQVkp9NSQsoKpJLDYuf08406V-hyfAfBP7s-xroPtAs1wMsEVnp1L/s640/blogger-image--131357088.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=014-e15&t=c">Los Angeles Times</a> (3/9, Kaplan) reports in “Science Now” that “ultra-processed foods” now “make up 58% of all calories Americans consume in a typical day,” a <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=015-0cc&t=c">study</a>published in BMJ Open reveals.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=016-ea8&t=c">TIME</a> (3/9, Park) reports that the study also found that “this type of processed food as the main source of added sugar in the US diet.” The study defined ultra-processed food “as food that contains ingredients such as flavors, colors, sweeteners and hydrogenated oils, emulsifiers and other additives that you wouldn’t cook with at home.” Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=017-1b6&t=c">Newsweek</a> (3/9, Firger), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=018-6f8&t=c">STAT</a> (3/9, Samuel), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=019-905&t=c">MedPage Today</a> (3/9, Brown), and <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016031001tma&r=7000424-3644&l=01a-889&t=c">HealthDay</a> (3/9, Reinberg).</span></font></p></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com2tag:blogger.com,1999:blog-1619592806979659394.post-8708386131592552252016-02-22T19:15:00.001-06:002016-02-22T19:15:04.346-06:00BMI mislabels 54 million Americans as 'overweight' or 'obese,' study
says<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjaLgX57YIr1ww4cyZjGv3Xa80nu2j-Y2ROTv4ya83XJXpLGEvA25g_2JbE-pp2EKJjT4Pg8TGMSAG_L7XGCrhNvcW0Eh1TcuBQiWQphYqq6MJlgGT1mm-9J40gSDmIXdRVnBkish4u1-q/s640/blogger-image--2053755713.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjjaLgX57YIr1ww4cyZjGv3Xa80nu2j-Y2ROTv4ya83XJXpLGEvA25g_2JbE-pp2EKJjT4Pg8TGMSAG_L7XGCrhNvcW0Eh1TcuBQiWQphYqq6MJlgGT1mm-9J40gSDmIXdRVnBkish4u1-q/s640/blogger-image--2053755713.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;">http://www.latimes.com/science/sciencenow/la-sci-sn-bmi-does-not-measure-health-20160204-story.html</div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><article class="trb_ar" itemscope="" itemtype="http://schema.org/Article" style="margin: 0px; padding: 0px 20px; border-top-width: 1px; border-top-style: solid; border-top-color: rgb(204, 204, 204);"><div class="trb_ar_main"><div class="trb_ar_la" style="width: calc(100% + 40px); margin: 0px 0px 13px -20px;"><aside class="trb_embed " data-content-id="85795477" data-content-size="leadart" data-content-type="image" data-content-slug="la-sci-sn-bmi-does-not-measure-health-20160204-001" data-content-subtype="photo" data-role="socialshare_item imgsize_ratiosizecontainer " data-state=" " style="margin: 0px; padding: 0px; position: relative; width: 414px; overflow: hidden;"><div class="trb_embed_media "><div class="trb_embed_related" data-role="lightbox_metadata"><div class="trb_embed_related_credit_and_caption" style="margin: 10px 20px 5px; line-height: 17px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><p style="width: auto; line-height: 17px; display: inline;">A new study out of UCLA finds that people with high BMIs categorizing them as overweight or obese might actually be quite healthy according to more reliable markers of health. </p> (Wang Zhide / Getty Images)</span></div></div></div></aside></div><div><div class="trb_ar_by" style="display: table; margin: 5px 0px 15px;"><figure class="trb_ar_by_i_f" style="display: table-cell; margin: 0px; padding: 0px 10px 0px 0px; width: 70px;"><img src="http://www.trbimg.com/img-53607431/turbine/la-bio-amina-khan/70/70x70" srcset="http://www.trbimg.com/img-53607431/turbine/la-bio-amina-khan/140/140x140 2x, http://www.trbimg.com/img-53607431/turbine/la-bio-amina-khan/210/210x210 3x" alt="Amina Khan " width="70" height="70" title="Amina Khan " class="trb_ar_by_i" style="display: block; margin: 0px; padding: 0px; border: none; border-top-left-radius: 50%; border-top-right-radius: 50%; border-bottom-right-radius: 50%; border-bottom-left-radius: 50%;"></figure><span class="trb_ar_by_nm_pm" style="display: table-cell; vertical-align: middle;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span data-byline-withoutby="" class="trb_ar_by_nm_au" style="display: inline; font-weight: 700; line-height: 1;"><a itemprop="author" class="trb_ar_by_nm_au_a" href="http://www.latimes.com/la-bio-amina-khan-staff.html#nt=byline" style="display: inline; line-height: 1; text-decoration: none;">Amina Khan </a></span><span class="trb_ar_by_b" style="vertical-align: middle; display: inline-block; margin-top: -3px;"></span><a class="trb_ar_by_cl" href="mailto:amina.khan@latimes.com?subject=Regarding:%20%22BMI%20mislabels%2054%20million%20Americans%20as%20'overweight'%20or%20'obese,'%20study%20says%22" data-role="socialshare_sEmail" style="display: inline; font-weight: 700; line-height: 1; text-decoration: none;">Contact Reporter</a></span></span></div><div class="trb_ar_dateline" style="line-height: 13px; margin-top: 25px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><time itemprop="datePublished" class="trb_ar_dateline_time" data-datetime-month="February" data-datetime-day="4" data-datetime-year="2016" data-datetime-clock="1:40 PM" datetime="2016-02-04T13:40:00PST"></time></span></div></div><div itemprop="articleBody"><div class="trb_ar_page" data-role="pagination_page" data-content-page="1"><p style="margin-bottom: 18px; line-height: 24px; margin-top: 13px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Good news for some in the high-BMI crowd: A new study from UCLA finds that some 54 million Americans who are labeled as obese or overweight according to their body mass index are, when you take a closer look, actually healthy.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The findings, published in the International Journal of Obesity, reveal that employers could potentially saddle people with unfairly high health insurance costs based on a deeply flawed measure of actual health.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">“This should be a final nail in the coffin for BMI,” said lead author A. Janet Tomiyama, a psychologist at UCLA.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="font-weight: 700; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="https://www.facebook.com/latimes/posts/10153983946643010" target="_blank" rel="nofollow" style="text-decoration: none;">Join the conversation on Facebook >></a></span></p><span class="trb_ar_cont" data-ar-cont="Article continues below" style="display: block; margin: 0px 0px 8px; padding-top: 4px;"></span><aside class="trb_ar_sponsoredmod" data-adloader-networktype="yieldmo" data-role="delayload_item" data-screen-size="mobile" data-withinviewport-options="bottomOffset=100&topOffset=1000000" data-load-method="trb.vendor.yieldmo.init" data-load-type="method" style="margin: 0px 0px 25px; padding: 0px; clear: both;"><div id="ym_1082601812867266781@2128635607" data-id="ym_1" class="ym ym_scroll" style="margin: 0px auto; position: relative; width: 100% !important;"></div></aside><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Body mass index is calculated by dividing a person’s weight in kilograms by the square of the person’s height in meters. <a href="http://1.usa.gov/1VRAwQq" target="_blank" style="text-decoration: none;">According to</a> the <a title="U.S. Centers for Disease Control and Prevention" href="http://www.latimes.com/topic/health/diseases-illnesses/u.s.-centers-for-disease-control-prevention-ORGOV000011-topic.html" style="text-decoration: none;">Centers for Disease Control and Prevention</a>, a “healthy” BMI is 18.5-24.9, an overweight BMI is 25-29.9 and an obese BMI is 30 or higher. The calculation has been seen as a slightly more nuanced way to measure health than weight alone.</span></p><aside class="trb_embed " data-content-id="85560950" data-content-size="small" data-content-type="story" data-content-slug="la-sci-sn-bariatric-surgery-mental-health-20160112" data-content-subtype="story" data-role="socialshare_item imgsize_ratiosizecontainer " style="margin: 11px 20px 35px 0px; padding: 0px; position: relative; width: 175px; overflow: hidden; float: left; z-index: 1;"><div class="trb_embed_media "><span data-content-kicker="Related" style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"></span><a class="trb_embed_media_link" href="http://www.latimes.com/science/sciencenow/la-sci-sn-bariatric-surgery-mental-health-20160112-story.html" data-content-media-present="true" style="position: relative; display: block; float: left; width: 175px; text-decoration: none;"><figure data-role="imgsize_item" class="trb_embed_imageContainer_figure" imgheight="100" imgwidth="200" imgratio="16x9" style="margin: 4px 0px 10px; padding: 0px 0px 98.4375px; position: relative; width: 175.34375px; height: 0px; overflow: hidden;"><img itemprop="image" data-baseurl="http://www.trbimg.com/img-569536ff/turbine/la-sci-sn-bariatric-surgery-mental-health-20160112" alt="Weight-loss surgery may reduce depression in some patients, study suggests" class="trb_embed_imageContainer_img" title="Weight-loss surgery may reduce depression in some patients, study suggests" data-c-nd="1024x591" data-ratio="16x9" data-width="200" data-height="100" src="http://www.trbimg.com/img-569536ff/turbine/la-sci-sn-bariatric-surgery-mental-health-20160112/200/200x113" style="display: block; margin: auto !important; padding: 0px !important; border: none; max-width: 100.69999694824219%; max-height: 100.69999694824219%; position: absolute; left: 0px; right: 0px; top: 0px; bottom: 0px; width: auto !important;"></figure></a><div class="trb_embed_related" data-role="lightbox_metadata"><a class="trb_embed_media_link" href="http://www.latimes.com/science/sciencenow/la-sci-sn-bariatric-surgery-mental-health-20160112-story.html" style="text-decoration: none; position: relative; display: block; float: left; width: 175px;"><span class="trb_embed_related_title" style="display: block; padding-bottom: 5px; padding-top: 0px; word-wrap: break-word; line-height: 24px;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Weight-loss surgery may reduce depression in some patients, study suggests</span></font></span></a></div></div></aside><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">But over time, researchers have begun to suspect that people with so-called “healthy” BMIs can be very unhealthy, and those with high BMIs can actually be in very good shape.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">“The public is used to hearing ‘obesity,’ and they mistakenly see it as a death sentence,” Tomiyama said. “But obesity is just a number based on BMI, and we think BMI is just a really crude and terrible indicator of someone’s health.”</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">That would be a pretty big deal, especially since the U.S. Equal Employment Opportunity Commission recently proposed rules that would allow employers to penalize employees for up to 30% of their health insurance costs if they don’t meet 24 health criteria — which include meeting a specific BMI. If body mass index doesn’t accurately reflect health, then those with high BMIs potentially could be overcharged for no reason.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="font-weight: 700; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://www.latimes.com/science/popular/" style="text-decoration: none;">See the most-read stories in Science this hour >></a></span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">To find out whether BMI correlated with actual markers of health, a team of UCLA researchers analyzed data from 40,420 individuals who participated in the 2005-2012 National Health and Nutrition Examination Survey. They looked at individuals’ blood pressure, triglycerides, cholesterol, glucose, insulin resistance and C-reactive protein data — markers that are linked to heart disease and inflammation, among other issues.</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">They found that nearly half (47.4%) of overweight people and 29% of obese people were, from a metabolic standpoint, quite healthy. On the flip side, more than 30% of individuals with “normal” weights were metabolically unhealthy. </span></p><aside class="trb_embed " data-content-id="84977691" data-content-size="small" data-content-type="story" data-content-slug="la-sci-sn-pear-vs-apple-trumps-bmi-obesity-20151109" data-content-subtype="story" data-role="socialshare_item imgsize_ratiosizecontainer " style="margin: 11px 20px 35px 0px; padding: 0px; position: relative; width: 175px; overflow: hidden; float: left; z-index: 1;"><div class="trb_embed_media "><span data-content-kicker="Related" style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"></span><a class="trb_embed_media_link" href="http://www.latimes.com/science/sciencenow/la-sci-sn-pear-vs-apple-trumps-bmi-obesity-20151109-story.html" data-content-media-present="true" style="position: relative; display: block; float: left; width: 175px; text-decoration: none;"><figure data-role="imgsize_item" class="trb_embed_imageContainer_figure" imgheight="100" imgwidth="200" imgratio="16x9" style="margin: 4px 0px 10px; padding: 0px 0px 98.4375px; position: relative; width: 175.34375px; height: 0px; overflow: hidden;"><img itemprop="image" data-baseurl="http://www.trbimg.com/img-564126d8/turbine/la-sci-sn-pear-vs-apple-trumps-bmi-obesity-20151109" alt="Pear-shaped vs. apple trumps body mass index as a measure of risk" class="trb_embed_imageContainer_img" title="Pear-shaped vs. apple trumps body mass index as a measure of risk" data-c-nd="1024x681" data-ratio="16x9" data-width="200" data-height="100" src="http://www.trbimg.com/img-564126d8/turbine/la-sci-sn-pear-vs-apple-trumps-bmi-obesity-20151109/200/200x113" style="display: block; margin: auto !important; padding: 0px !important; border: none; max-width: 100.69999694824219%; max-height: 100.69999694824219%; position: absolute; left: 0px; right: 0px; top: 0px; bottom: 0px; width: auto !important;"></figure></a><div class="trb_embed_related" data-role="lightbox_metadata"><a class="trb_embed_media_link" href="http://www.latimes.com/science/sciencenow/la-sci-sn-pear-vs-apple-trumps-bmi-obesity-20151109-story.html" style="text-decoration: none; position: relative; display: block; float: left; width: 175px;"><span class="trb_embed_related_title" style="display: block; padding-bottom: 5px; padding-top: 0px; word-wrap: break-word; line-height: 24px;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Pear-shaped vs. apple trumps body mass index as a measure of risk</span></font></span></a></div></div></aside><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">“The reason I think people rely on BMI is because it’s easy; if you know someone’s weight and you know someone’s height, then out pops this magical number,” Tomiyama said. “But getting blood pressure is pretty easy too. It takes maybe 20 seconds if you have the machine. And so I really think focusing on better health markers like blood pressure is a better way to go about it — particularly when we’re talking about financial penalties.”</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Their results showed that using BMI as the primary indicator of health means that 74.9 million adults in the U.S. are being miscategorized as healthy or unhealthy. (That includes the 34.4 million people who are considered overweight and the 19.8 million people considered obese, according to BMI.)</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">“Policymakers should consider the unintended consequences of relying solely on BMI,” the authors wrote in the study, “and researchers should seek to improve diagnostic tools related to weight and cardiometabolic health.”</span></p><p style="margin-bottom: 18px; line-height: 24px;"><span style="font-weight: 700; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Follow <a href="http://bit.ly/12JLVeP" target="_blank" style="text-decoration: none;">@aminawrite</a> on Twitter for more science news and "like" Los Angeles Times Science & Health on <a href="https://www.facebook.com/latimesscience" target="_blank" style="text-decoration: none;">Facebook</a>.</span></p></div></div></div></article><div class="trb_ar_e_d" data-role="extendablePage_summaryStart" data-load-type="scrollintoview" style="font-family: -webkit-standard; font-size: 10px; -webkit-text-size-adjust: 100%; background-color: rgb(255, 255, 255);"></div></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com1tag:blogger.com,1999:blog-1619592806979659394.post-86980469480586676862016-01-13T07:56:00.001-06:002016-01-13T07:56:33.841-06:00Proton Pump Inhibitors May Be Linked To Higher Rates Of CKD.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4f0C8x0bzXjfc9MQmgEudBV-lQHdvOmvAmnAVBYB-qaspiCLJ5hte7pA-1TjiFgOX9DY9BwzIgo0gEsFEPwMc2F5lIhGVGjPCB8w845Zlc5bhfnk_kgFWF3q_qt3YjLfgvZY-5B5ZHe9u/s640/blogger-image-2140839624.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi4f0C8x0bzXjfc9MQmgEudBV-lQHdvOmvAmnAVBYB-qaspiCLJ5hte7pA-1TjiFgOX9DY9BwzIgo0gEsFEPwMc2F5lIhGVGjPCB8w845Zlc5bhfnk_kgFWF3q_qt3YjLfgvZY-5B5ZHe9u/s640/blogger-image-2140839624.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><div class="story-text-div" style="margin-top: 7px; margin-bottom: 10px; line-height: 18px; text-align: justify; border: 0px !important; padding: 0px !important; margin-left: 0px !important; margin-right: 0px !important;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=032-86f&t=c">Washington Post</a> (1/12, Bernstein) “To Your Health” blog reports that <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=033-d70&t=c">research</a> published in JAMA Internal Medicine suggests that proton pump inhibitors may be linked to “higher rates of chronic kidney disease [CKD].” Researchers “studied the records of more than 10,000 people treated in community-based settings.” The investigators “found a 20 percent to 50 percent greater risk of the onset of” CKD “among users of the drugs than those who did not take them.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=034-927&t=c">NPR</a> (1/12, Stein) “Shots” blog reports that the investigators also studied “248,751 patients in the Geisinger Health System in Pennsylvania.” The data indicated that “the 10-year absolute risk” for CKD “among the 16,900 patients using PPIs in the” health system “was 15.6 percent, whereas 13.9 percent would have been expected to develop” CKD. Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=035-32f&t=c">Reuters</a> (1/12, Rapaport), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=036-d43&t=c">HealthDay</a> (1/12, Thompson), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=037-216&t=c">MedPage Today</a> (1/12, Boyles), and <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016011201tma&r=7000424-d050&l=038-98d&t=c">Medscape</a> (1/12, Kelly).</span></p><div style="color: rgb(51, 51, 51); font-family: arial, verdana, sans-serif; font-size: 12px; -webkit-text-size-adjust: auto;"><br></div></div><a name="prevdayleadstories" style="font-family: arial, verdana, sans-serif; -webkit-text-size-adjust: auto;"></a><span style="font-family: arial, verdana, sans-serif; font-size: medium; -webkit-text-size-adjust: auto; background-color: rgb(255, 255, 255);"></span></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-43494683238681933742016-01-08T21:26:00.001-06:002016-01-08T21:26:32.646-06:00HHS, USDA Release Updated Dietary Guidelines.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgg8CqbMYp-OYKzTb8wO7lNT6wg19wJbEkKOIW5hv_cJmFhXvxxf12Ul9yLy4wKojyHkg5e7V8mhfEjFYE6LbPUz25I4IHvfgLyc9JmvR2YRgPv6StDAY-jIFbD3ZS4gwYxGvXeCQ1S8vFQ/s640/blogger-image--211517707.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgg8CqbMYp-OYKzTb8wO7lNT6wg19wJbEkKOIW5hv_cJmFhXvxxf12Ul9yLy4wKojyHkg5e7V8mhfEjFYE6LbPUz25I4IHvfgLyc9JmvR2YRgPv6StDAY-jIFbD3ZS4gwYxGvXeCQ1S8vFQ/s640/blogger-image--211517707.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <u>CBS Evening News</u> (1/7, story 9, <a dir="ltr" href="x-apple-data-detectors://2" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="2">2:10</a>, Pelley) reported, “Today the government revised its advice for a healthy diet. The headlines: Lean meat and eggs may now be okay, but sugar and salt still bad.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016010801tma&r=7000424-beb1&l=002-02a&t=c">USA Today</a> (1/8, Szabo) reports that the new guidelines, from the US Department of Agriculture and the US Department of Health and Human Services, recommend “limiting the amount of added sugars in our diet to no more than 10% of daily calories,” which is approximately “12 teaspoons of sugar a day.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016010801tma&r=7000424-beb1&l=003-ee7&t=c">Los Angeles Times</a> (1/8, Healy) reports, “Essentially, the latest edition of the Dietary Guidelines for Americans nudges the country’s nutritional policy toward a traditional Mediterranean diet.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016010801tma&r=7000424-beb1&l=004-009&t=c">AP</a> (1/8, Jalonick) reports that reducing “sodium intake was the major push of the 2010 guidelines, and that document recommended that those most at risk of heart disease, or about half the population, lower their intake to 1,500 mg.” However, “the new guidelines delete that lower amount as part of the top recommendations.” But, “the report says those with high blood pressure and prehypertension could benefit from a steeper reduction.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">However, according to the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2016010801tma&r=7000424-beb1&l=005-2ec&t=c">New York Times</a> (1/8, A3, O'Connor), “the guidelines were also notable for what they did not say.” Although “draft recommendations had suggested all Americans adopt more environmentally-sustainable eating habits by cutting back on meat, that advice was dropped from the final guidelines.” Meanwhile, “longstanding limits on dietary cholesterol were also removed.”</span></p></div><div class="separator" style="clear: both;"><br></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com1tag:blogger.com,1999:blog-1619592806979659394.post-46634943389437285962015-11-18T23:10:00.001-06:002015-11-18T23:10:36.775-06:00Dallas-Based Dietary Supplement Maker Indicted For Fraud As Part Of
“Widespread Crackdown.”<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi5OlkkMaYU12jHF3dH_qqRALTZEeu-63-dtEY0-sUDEK3mPyxpQQm0Lb6pojEgFT-d-_JdCA3GdiXwXDbiHpfCMpidKyv3aVyaPAlEJ2yEg0pboEUhyphenhyphenzoCNyew6JtQVEj8IW9Y4VWZvubC/s640/blogger-image-527538144.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi5OlkkMaYU12jHF3dH_qqRALTZEeu-63-dtEY0-sUDEK3mPyxpQQm0Lb6pojEgFT-d-_JdCA3GdiXwXDbiHpfCMpidKyv3aVyaPAlEJ2yEg0pboEUhyphenhyphenzoCNyew6JtQVEj8IW9Y4VWZvubC/s640/blogger-image-527538144.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=002-259&t=c">Wall Street Journal</a> (11/18, Burton, Subscription Publication) reports that dietary supplement maker USPlabs LLC and its executives were charged with fraud by a Federal grand jury in Texas on Tuesday. Officials from the Justice Department, the Food and Drug Administration, the Federal Trade Commission, the US Postal Inspection Service, and other agencies say the indictment was part of a nationwide effort targeting illegal marketing of dietary supplements.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=003-0e4&t=c">New York Times</a> (11/17, B2, O'Connor) reports in its “Well” blog that the USPlabs indictment is “at the center” of a “yearlong federal investigation into the dietary supplement industry,” resulting in a “widespread crackdown on more than 100 companies accused of selling tainted or misleading products.” USPlabs sold a supplement, OxyElite Pro, linked to a 2013 outbreak of liver disease that killed one person and sickened 97 people.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=004-21e&t=c">Bloomberg News</a> (11/17, Mittelman, Townsend) reports that SK Laboratories Inc., “which makes supplements for USPlabs, was also charged in the case.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=005-2d9&t=c">AP</a> (11/18, Tucker) reports that USPlabs was directed by the FDA to recall its OxyElite Pro product in 2013, and while it told the agency it would stop distributing it, it instead began a “surreptitious, all-hands-on-deck effort to sell as much OxyElite Pro as it could as quickly as possible,” according to the criminal complaint.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=006-41d&t=c">Washington Post</a> (11/17, Merle, Dennis) reports that USPlabs allegedly told retailers that some of its products had natural plant extracts that were actually a synthetic stimulant made in a chemical factory in China, the DOJ complaint alleges.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=007-1ef&t=c">The Hill</a> (11/18, Wheeler) reports that the DOJ also filed civil cases against Vibrant Life, Viruxo, Optimum Health, Bethel Nutritional Consulting and Regeneca Worldwide. The Federal Trade Commission “has also taken civil actions against Sunrise Nutraceuticals LLC, Health Nutrition Products and NPB Advertising Inc.” for allegedly “making false, misleading or unsubstantiated health and [effectiveness] claims.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=008-3f3&t=c">Reuters</a> (11/18, Bartz), a separate <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=009-771&t=c">Bloomberg News</a> (11/18, McLaughlin) article, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00a-d13&t=c">CBS News</a> (11/18, Gibson) website, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00b-7c8&t=c">NBC News</a> (11/18, Fox) website, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00c-321&t=c">NPR</a> (11/17, Wagner) “The Two-Way,” the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00d-5e3&t=c">Dallas Morning News</a> (11/18, Lindenberger), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00e-05b&t=c">Stat</a> (11/17, Swetlitz), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=00f-c57&t=c">Vox</a> (11/17, Belluz), and the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111801tma&r=7000424-106c&l=010-aa1&t=c">Food Safety News</a>(11/18, Flynn).</span></p></div><div class="separator" style="clear: both;"><br></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-39650154098380869562015-11-17T18:17:00.001-06:002015-11-17T18:17:25.959-06:00FDA Approves Drug To Treat Multiple Myeloma.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBYMizIhu0iRDmeyNqYt0qsUQhZ_M4pKjgGYeJgzsAiD2Y6YH8ZgqNFpjaTVlXO19E0t-_oSVcTY5pCQMCrdEKXPaQJH9OvYAIFALOEQACp_02xjCzrjO7MRfv23N-2UTabgOTsOzE4vkw/s640/blogger-image-69552626.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBYMizIhu0iRDmeyNqYt0qsUQhZ_M4pKjgGYeJgzsAiD2Y6YH8ZgqNFpjaTVlXO19E0t-_oSVcTY5pCQMCrdEKXPaQJH9OvYAIFALOEQACp_02xjCzrjO7MRfv23N-2UTabgOTsOzE4vkw/s640/blogger-image-69552626.jpg"></a></div><div class="separator" style="clear: both;">Source: http://www.cancer.gov/images/cdr/live/CDR763079-750.jpg</div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=01b-339&t=c">AP</a> (11/17, Johnson) reports that the Food and Drug Administration approved Johnson & Johnson’s Darzalex (daratumumab), a drug “for treating the incurable blood cancer multiple myeloma in patients who’ve failed prior therapies and have few options left.” The drug is not only the first biologic, but also the first monoclonal antibody approved to treat multiple myeloma.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=01c-d21&t=c">Reuters</a> (11/17, Pierson), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=01d-a62&t=c">HealthDay</a> (11/17, Roberts), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=01e-7e1&t=c">MedPage Today</a> (11/17, Bankhead), and <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=01f-7b6&t=c">Medscape</a> (11/17, Chustecka).</span></p></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-46512182296296886832015-11-17T18:09:00.001-06:002015-11-17T18:09:48.775-06:00WHO Survey Indicates People Lack Understanding Of Antibiotics.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj22qzeZZ8WWmBuqwnxt2_d3My9MS72RSCvSw8pMY5U7h_pUJr5Apn_c5unVvN4dnGtSK3WwM2Qf-kAhaiVSoPQFYVurNdZVfS5Xmgyu9lNNyqtjb3sDx_q0RQPaKPPfK-8gDl5aVcDzXdY/s640/blogger-image-1664255082.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj22qzeZZ8WWmBuqwnxt2_d3My9MS72RSCvSw8pMY5U7h_pUJr5Apn_c5unVvN4dnGtSK3WwM2Qf-kAhaiVSoPQFYVurNdZVfS5Xmgyu9lNNyqtjb3sDx_q0RQPaKPPfK-8gDl5aVcDzXdY/s640/blogger-image-1664255082.jpg"></a></div><div class="separator" style="clear: both;">Image Source: http://ibraheem-altowaiher.deviantart.com/art/Antibiotics-MD-198124195</div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=009-744&t=c">Reuters</a> (11/17, Kelland) reports that according to the World Health Organization, peoples’ misunderstanding and ignorance of antibiotics is contributing to the increase in drug-resistant pathogens. A survey released by the WHO revealed that 64 percent of participants incorrectly believed that antibiotics could be used to treat colds and the flu. Additionally, a third of people surveyed believed that they should stop taking antibiotics when they feel better instead of completing the entire treatment course as prescribed.</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=00a-37b&t=c">CBS News</a> (11/17) reports on its website that the WHO “surveyed nearly 10,000 people across 12 countries as part of the CDC’s ‘Get Smart About Antibiotics Week,’-- an effort to stop the threat posed by resistance to antibiotics.” Meanwhile, another “76 percent of respondents believed antibiotic resistance meant the body was becoming resistant, but it is actually the bacteria that is becoming resistant.” <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111701tma&r=7000424-84e1&l=00b-d81&t=c">Medscape</a> (11/17, Brooks) also reports on the story.</span></font></p></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-66291010913588256862015-11-15T09:17:00.001-06:002015-11-15T09:17:29.082-06:00ESRD Risk Tool for Kidney Donor CandidatesBased on the latest NEJM 2015 article <div><br></div><div>http://www.transplantmodels.com/esrdrisk/</div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-65367175927133427332015-11-14T17:53:00.001-06:002015-11-14T17:53:10.036-06:00Is 120 mm Hg the new BP target? What headlines aren’t telling you<span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The results of the SPRINT trial are in, and you’ve probably heard that making 120 mm Hg the new blood pressure target helped lower mortality rates. Yet the study outcomes apply only to a specific subset of patients with hypertension. See whether or not your patients may fit into this category. <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111401amaweekend&r=6277520-0faf&l=00a-e61&t=c">Read more</a> at <i>AMA Wire®.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiyfKK3OG3yWIE3_gglEc2HL0G3-puoE_Ggdo_c-9JkiOJ_mYBksikQb8bBM4X3uuV3kWLS-jN37eHXeBlV3dYwXIF53YdBJU5mxKrOKM3cfVwU1sh9DnEO02ECXD5hZhHJac2y9-qG69u0/s640/blogger-image-707059337.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiyfKK3OG3yWIE3_gglEc2HL0G3-puoE_Ggdo_c-9JkiOJ_mYBksikQb8bBM4X3uuV3kWLS-jN37eHXeBlV3dYwXIF53YdBJU5mxKrOKM3cfVwU1sh9DnEO02ECXD5hZhHJac2y9-qG69u0/s640/blogger-image-707059337.jpg"></a></div></i></span>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-18176338300185950452015-11-10T22:58:00.001-06:002015-11-10T22:58:30.259-06:00Lowering Blood Pressure Target May Lead To Lower Rates Of CV Events.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9_snl6HHqdqqCHIFsuOCLRYNLGbkv4xJylVSYh1qkdl8JIOBZuP3RV2VBLB864aKSyCQhphyoMeTpVIfTDvVavw8pZm6C18a-pyH73zJV2Z7YtmwX7XP1qM4b6TBL07oZUWwiLi5wYGIw/s640/blogger-image-1664738036.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj9_snl6HHqdqqCHIFsuOCLRYNLGbkv4xJylVSYh1qkdl8JIOBZuP3RV2VBLB864aKSyCQhphyoMeTpVIfTDvVavw8pZm6C18a-pyH73zJV2Z7YtmwX7XP1qM4b6TBL07oZUWwiLi5wYGIw/s640/blogger-image-1664738036.jpg"></a></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <u>CBS Evening News</u> (11/9, story 9, <a dir="ltr" href="x-apple-data-detectors://6" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="6">1:25</a>, Pelley) reported that “a new study that says sharply lower blood pressure leads to significantly longer lives.” On <u>ABC World News</u>(11/9, story 8, <a dir="ltr" href="x-apple-data-detectors://8" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="8">1:00</a>, Muir), ABC’s Dr. Richard Besser reported, “The results were so startling, they stopped the study...early.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">In a 1,300-word article, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111001tma&r=7000424-e71a&l=006-c70&t=c">New York Times</a> (11/10, Kolata, Subscription Publication) reports that investigators found that “among the 9,361 hypertension patients followed for an average of 3.2 years, there were 27 percent fewer deaths (155 compared with 210) and 38 percent fewer cases of heart failure (62 compared with 100) among patients who achieved the systolic pressure target of 120 than among those who achieved the current 140 target.” Altogether, “there was a 25 percent reduction — 243 compared with 319 — in people who had a heart attack, heart failure or stroke or died from heart disease, Dr. Paul K. Whelton, a principal investigator for the study, said.” The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111001tma&r=7000424-e71a&l=007-eec&t=c">findings</a> were presented at the American Heart Association meeting and published in the New England Journal of Medicine.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111001tma&r=7000424-e71a&l=008-b4c&t=c">AP</a> (11/10, Marchione) reports that “too-low blood pressure, fainting episodes and more worrisome, kidney problems were 1 percent to 2 percent higher in the lower pressure group.” However, “falls that cause injury due to lightheadedness were not more common, as had been feared especially for older people.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015111001tma&r=7000424-e71a&l=009-c71&t=c">Seattle Times</a> (11/10, Aleccia) reports that “the study, dubbed the Systolic Blood Pressure Intervention Trial — or SPRINT — was stopped in September, nearly two years early, when it became clear that radically lowering blood pressure for many people older than 50 helped prevent heart attacks and other heart problems and deaths.”</span></p></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><br></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-17280990217847958102015-10-30T19:26:00.001-05:002015-10-30T19:26:45.837-05:00Reduced-Fat Diets No More Effective Than Other Weight-Loss Diets,
Meta-Analysis Suggests.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgSVtDt3OZKKWmmNrx_9Eslim85SaPsYnNlpgOkd2AhJR463vPkczHn3NXdBY0WBH2L0XiSGCjNOwvyY4xBfEheRmfZaG4FlPLeCxN8s4S670s5uSE41wrOuoG8TLGfm1VXVrBxs4Qg6rvt/s640/blogger-image-301136418.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgSVtDt3OZKKWmmNrx_9Eslim85SaPsYnNlpgOkd2AhJR463vPkczHn3NXdBY0WBH2L0XiSGCjNOwvyY4xBfEheRmfZaG4FlPLeCxN8s4S670s5uSE41wrOuoG8TLGfm1VXVrBxs4Qg6rvt/s640/blogger-image-301136418.jpg"></a></div><div class="separator" style="clear: both;"><br></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=028-c0d&t=c">Bloomberg News</a> (10/29, Tozzi) reports that a <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=029-901&t=c">meta-analysis</a> published Oct. 29 in The Lancet Diabetes & Endocrinology “finds reducing fat isn’t any more effective for losing weight than other diets.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02a-05b&t=c">CBS News</a> (10/29, Marcus) website reports that after analyzing data from “53 studies” including “more than 68,000 adults,” researchers found that “reduced-fat diets only led to more weight loss when compared with no diet at all.” Individuals “on low-carbohydrate diets lost substantially more weight than those who went the low-fat route.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02b-95c&t=c">TIME</a> (10/29, Sifferlin) reports that the study authors concluded that “public health guidelines should stop recommending low-fat diets for weight loss, stressing that more research is needed to find what strategy is most effective and able to be maintained.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02c-a7e&t=c">CNBC</a> (10/29, Ferris), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02d-8b9&t=c">Vox</a>, <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02e-7d2&t=c">HealthDay</a> (10/29, Doheny), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=02f-fc0&t=c">AFP</a> (10/29), the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=030-fee&t=c">Telegraph (UK)</a> (10/29, Donnelly), and <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015103001tma&r=7000424-980f&l=031-942&t=c">The Guardian (UK)</a> (10/29, Boseley).</span></p></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-54938862584659004002015-10-23T14:59:00.001-05:002015-10-23T14:59:38.496-05:00FDA Warns Hepatitis C Drugs Could Cause Severe Liver Damage To Patients
With Underlying Liver Disease.<div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhQFtL4r3uIyim1ZnoDXP6ERccnlXxsChU3lxbEQO3v7IkG2pw6V3PwkR5wR5fDhQm-fthGFzwuTj_87iUIz41iXgDEXmQtqhhPOspHszMSMLSx3GKLYKfPc2HhvwMXU4wCsD5wIk6pKzLf/s640/blogger-image--501837368.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhQFtL4r3uIyim1ZnoDXP6ERccnlXxsChU3lxbEQO3v7IkG2pw6V3PwkR5wR5fDhQm-fthGFzwuTj_87iUIz41iXgDEXmQtqhhPOspHszMSMLSx3GKLYKfPc2HhvwMXU4wCsD5wIk6pKzLf/s640/blogger-image--501837368.jpg"></a></div><div class="separator" style="clear: both;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015102301tma&r=7000424-ef39&l=002-ad8&t=c">Wall Street Journal</a> (10/23, Loftus, Subscription Publication) reports that the Food and Drug Administration issued a warning on Thursday that AbbVie Inc.’s Viekira Pak (ombitasvir/paritaprevir/ritonavir with dasabuvir) and Technivie (ombitasvir/paritaprevir/ritonavir) may cause severe liver damage to patients who have an underlying liver disease.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015102301tma&r=7000424-ef39&l=003-013&t=c">Washington Post</a> (10/23, Dennis) reports that the FDA said it had received reports of at least 26 cases since late 2014 of patients “who either died or had to undergo liver transplantation” after taking the hepatitis C drugs, with the liver damage occurring in the first month of treatment. According to the Post, the agency “will require AbbVie to add new warnings to the safety labels of the drugs for patients who already have advanced liver disease linked to hepatitis C” and “urged doctors to closely monitor patients taking the drugs for symptoms of worsening liver disease.” <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015102301tma&r=7000424-ef39&l=004-bc9&t=c">Bloomberg News</a> (10/23, Bloomfield) and the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015102301tma&r=7000424-ef39&l=005-f72&t=c">AP</a> (10/23, Perrone) also cover the story.</span></p></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-33534046926505973092015-10-07T00:59:00.001-05:002015-10-07T00:59:06.662-05:00Late Bedtimes May Be Linked To Weight Gain Over Time.<p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"></span></p><div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgejF4fuNf5KpsxsPLfz6Hps8rzzNMu4nv-6pNbEWSSRitRlU35Shyphenhyphen_2wEIv7VqND98xudad_bcj2XVzSF4wGTpxaqO2ylqHhVtXvlZ208WdQbKERbLz_ExdbmC2NKFMnNu73MQThWEdFOJ/s640/blogger-image-1055385301.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgejF4fuNf5KpsxsPLfz6Hps8rzzNMu4nv-6pNbEWSSRitRlU35Shyphenhyphen_2wEIv7VqND98xudad_bcj2XVzSF4wGTpxaqO2ylqHhVtXvlZ208WdQbKERbLz_ExdbmC2NKFMnNu73MQThWEdFOJ/s640/blogger-image-1055385301.jpg"></a></div><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><br></p><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">On its website, <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015100501tma&r=7000424-0f65&l=021-8af&t=c">CBS News</a> (10/3, Welch) reported that <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015100501tma&r=7000424-0f65&l=022-b5f&t=c">research</a> published in Sleep suggests that “going to bed later during the workweek is associated with weight gain over time.” Investigators looked at “data on more than 3,300 teens and young adults recorded at different intervals over the course of about 15 years.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015100501tma&r=7000424-0f65&l=023-d10&t=c">HealthDay</a> (10/3, Preidt) reported that the investigators “found that each extra hour of late bedtime was associated with a more than two-point increase in body mass index (BMI).” The data indicated that the association “between late bedtimes and BMI increase was not significantly affected by total sleep time, amount of exercise, or time spent in front of computers or televisions.”</span></font></p>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-42271797969297747582015-09-30T23:31:00.001-05:002015-09-30T23:31:49.040-05:00Calcium Supplements May Not Strengthen Bones In Women Under 80, Study
Finds.<div class="story-text-div" style="margin-top: 7px; margin-bottom: 10px; line-height: 18px; text-align: justify; border: 0px !important; padding: 0px !important; margin-left: 0px !important; margin-right: 0px !important;"><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"></p><figure class="img_main-art-wrapper bleed" style="box-sizing: inherit; display: block; margin: 0px -9px; clear: both; position: relative; color: rgb(35, 35, 35); font-family: ProximaNovaRegular, 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.301961); -webkit-text-size-adjust: 100%; -webkit-text-stroke-width: 0px;"></figure><p></p><div class="article-hed_overlay article-header article-header_overlay" style="box-sizing: inherit; position: absolute; bottom: 18px; color: rgb(255, 255, 255); width: 718px; z-index: 5; text-shadow: rgba(0, 0, 0, 0.498039) 1px 1px 3px; border-top-width: 1px; border-top-style: solid; border-top-color: rgb(255, 255, 255); padding-top: 1.125em; margin-bottom: 0px; font-family: ProximaNovaRegular, 'Helvetica Neue', Helvetica, Arial, sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-tap-highlight-color: rgba(26, 26, 26, 0.301961); -webkit-text-size-adjust: 100%; -webkit-text-stroke-width: 0px;"><div class="article-hed" style="box-sizing: inherit;"><p class="byline_article" style="box-sizing: inherit; margin-top: 0px; margin-bottom: 0px; padding-top: 0px; padding-bottom: 0px; word-wrap: break-word; letter-spacing: 0.01rem; font-size: 0.7901234568em; line-height: 1.423828125;"><span class="byline" style="box-sizing: inherit; color: rgb(255, 255, 255); text-transform: uppercase; margin-right: 0.375em;"><span class="byline_author" itemprop="author" style="box-sizing: inherit; font-family: ProximaNovaSemiBold, 'Helvetica Neue', Helvetica, Arial, sans-serif;">FOX</span></span></p></div></div><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"></span></p><div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqhVUvpdsJ4_6qi_OK7z3sY5N2zqlvh537xP3eV2SQu50-vsALzC6HuJ4NhHsMgCsUG-yUm5kpyJ4T1tDnmxfLb5HfRfkOsPUdJ-aOMH0qWvIrt5boRcgbqtVcGgq4dvvi63UhQgU9t2Vk/s640/blogger-image-56475589.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqhVUvpdsJ4_6qi_OK7z3sY5N2zqlvh537xP3eV2SQu50-vsALzC6HuJ4NhHsMgCsUG-yUm5kpyJ4T1tDnmxfLb5HfRfkOsPUdJ-aOMH0qWvIrt5boRcgbqtVcGgq4dvvi63UhQgU9t2Vk/s640/blogger-image-56475589.jpg"></a></div><br><p></p><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><br></span></p><p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">David Muir reported on <u>ABC World News</u> (9/29, story 10, <a dir="ltr" href="x-apple-data-detectors://65" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="65">0:30</a>, Muir) that new research finds “taking daily calcium supplements does little to strengthen bones in women under 80.” Muir reported, “Only women over 80 and in nursing homes saw hip fractures decrease by 23 percent.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Correspondent Rehema Ellis reported on <u>NBC Nightly News</u> (9/29, story 7, <a dir="ltr" href="x-apple-data-detectors://67" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="67">2:15</a>, Holt) that investigators “concluded that most people over 50 won’t get stronger bones if they increase their calcium intake.” The findings were published in the British Medical Journal.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Meanwhile, <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015093001tma&r=7000424-7f89&l=029-1dd&t=c">NBC News</a> (9/30) reports on its website that the “extra calcium doesn’t go to strengthen bones but instead can build up in the arteries, causing heart disease, or in the kidneys, causing kidney stones.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015093001tma&r=7000424-7f89&l=02a-48f&t=c">TIME</a> (9/30, Sifferlin) reports the results from the meta-analysis “suggest that clinicians, advocacy organizations and health policymakers should not recommend increasing calcium intake for fracture prevention either with calcium supplements or through dietary sources,” the New Zealand researchers wrote. TIME adds that the “new results also fall in line with the guidance provided by the United States Preventative Services Task Force in 2013,” which, based on the evidence available, ultimately concluded that “post-menopausal women should not take daily supplements.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Also covering the story are <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015093001tma&r=7000424-7f89&l=02b-4f0&t=c">HealthDay</a> (9/30), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015093001tma&r=7000424-7f89&l=02c-d0b&t=c">LiveScience</a>(9/30), and the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015093001tma&r=7000424-7f89&l=02d-f76&t=c">Telegraph (UK)</a> (9/30).</span></p><div style="color: rgb(51, 51, 51); font-family: arial, verdana, sans-serif; font-size: 12px; -webkit-text-size-adjust: auto;"><br></div></div><a name="prevdayleadstories" style="font-family: arial, verdana, sans-serif; -webkit-text-size-adjust: auto;"></a><span style="font-family: arial, verdana, sans-serif; font-size: medium; -webkit-text-size-adjust: auto; background-color: rgb(255, 255, 255);"></span>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-66882867782826413092015-09-18T22:04:00.001-05:002015-09-18T22:04:44.092-05:00Diabetes Medication May Reduce Deaths From Cardiovascular Disease,
Study Suggests.<p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=020-55d&t=c">New York Times</a> (9/18, B2, Pollack, Subscription Publication) reports that “for the first time, a widely used modern diabetes” medication “has been shown to reduce deaths from cardiovascular disease, a long-sought goal of treatment, researchers announced” yesterday. The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=021-659&t=c">research</a>(9/18) was presented at the annual meeting of the European Association for the Study of Diabetes and published in The New England Journal of Medicine.</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">On its website, <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=022-682&t=c">NBC News</a> (9/17) reports that the medication, “called Jardiance [empagliflozin], lowered heart disease deaths by 38 percent and deaths from any cause by 32 percent over three years.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=023-494&t=c">AP</a> (9/18, Johnson) reports that the findings “were particularly striking because nearly four-fifths of the participants were already taking standard medicines to control blood sugar, blood pressure and cholesterol, plus taking either Jardiance or a” placebo.</span></p>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-62775667144780311562015-09-18T22:00:00.001-05:002015-09-18T22:00:26.617-05:00CDC Says Flu Vaccine May Be More Effective This Year.<p style="text-align: start; margin: 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <u>CBS Evening News</u> (9/17, story 12, <a dir="ltr" href="x-apple-data-detectors://34" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="34">1:45</a>, Pelley) reported that this year’s influenza vaccine may be more effective than last year’s. According to Dr. Jon Lapook, “Last year, the vaccine was only 23 percent effective because the predominant strain mutated after the vaccine had already been manufactured.” CDC “officials say this year’s flu vaccine is well-matched right now to circulating viruses.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=019-de2&t=c">Los Angeles Times</a> (9/18, Kaplan) reports that this year, “flu watchdogs at the CDC have scrutinized 199 flu specimens collected in the United States and elsewhere between May 24 and Sept. 5.” They found that “the majority of those specimens – 118 of them – were H3N2 viruses, and all of them were built in a way that should make them vulnerable to this year’s vaccines.”</span></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=01a-6be&t=c">McClatchy</a> (9/18, Mueller) reports that “by including components of H3N2 in this season’s flu vaccine, health care professionals hope to raise vaccine effectiveness against predominant strains back up to the 50 to 60 percent range.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px; line-height: 1.3em !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091801tma&r=7000424-2747&l=01b-dab&t=c">AP</a> (9/18, Neergaard) reports that, “all told, at least 171 million doses of flu vaccine are expected this year.” Meanwhile, Dr. Tom Frieden, director of the Centers for Disease Control and Prevention, said “it doesn’t matter which flu vaccine you get, just get one.”</span></p>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-61899108520731981202015-09-15T09:57:00.001-05:002015-09-15T09:57:56.734-05:00Guidelines For Chronic Kidney Disease Diagnosis Cause Debate Among
Physicians.<div style="text-align: start;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="text-align: justify;"><div class="separator" style="clear: both;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjc-qVAd829ATGmyoMQP9SGOncUmP4-dmNeiS9i3osKl2ojoOmtd2K-aeeX9N9xnBzok3k77_hRE5Wg2EgA5ktoIM0VPa6PLqkB6C_EiZB5YRRTM-pxpWL2iGIs3Eg-CiPTcAZcRlz6owGF/s640/blogger-image-619018557.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjc-qVAd829ATGmyoMQP9SGOncUmP4-dmNeiS9i3osKl2ojoOmtd2K-aeeX9N9xnBzok3k77_hRE5Wg2EgA5ktoIM0VPa6PLqkB6C_EiZB5YRRTM-pxpWL2iGIs3Eg-CiPTcAZcRlz6owGF/s640/blogger-image-619018557.jpg"></a></div><br></span></span></div><div style="text-align: start;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="text-align: justify;"><br></span></span></div><div style="text-align: start;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="text-align: justify;">The </span><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091501tma&r=7000424-3bd4&l=019-881&t=c" style="text-align: justify;">New York Times</a><span style="text-align: justify;"> (9/15, Span, Subscription Publication) reports that the guidelines for the diagnosis of chronic kidney disease are causing debate among physicians, with some arguing “that the guidelines should be recalibrated by age.” Authors of a recent viewpoint </span><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091501tma&r=7000424-3bd4&l=01a-c62&t=c" style="text-align: justify;">article</a><span style="text-align: justify;"> in JAMA “propose that in people older than 65, the diagnosis should require a G.F.R. [glomerular filtration rate] reading less than 45,” as opposed to the current reading of 60, which they estimate will reduce “a third to half of the chronic kidney disease diagnosed.” Authors of an opposing viewpoint </span><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091501tma&r=7000424-3bd4&l=01b-2b3&t=c" style="text-align: justify;">article</a><span style="text-align: justify;">, however, “warned against changing the guidelines,” saying that people need to know that they have low GFR levels in order to “take some steps to reduce the risk of eventual kidney failure, even if that’s already extremely low.”</span></span></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-17869825914746967642015-09-14T16:33:00.001-05:002015-09-14T16:33:27.451-05:00Aggressive Blood-Pressure Reduction May Reduce Cardiovascular Problems,
Deaths.<div class="story-text-div" style="margin-top: 7px; margin-bottom: 10px; text-align: justify; border: 0px !important; padding: 0px !important; margin-left: 0px !important; margin-right: 0px !important;"><p style="text-align: start; margin: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">During its Friday broadcast, <u>NBC Nightly News</u> (9/11, story 7, <a href="x-apple-data-detectors://26" x-apple-data-detectors="true" x-apple-data-detectors-type="calendar-event" x-apple-data-detectors-result="26">2:05</a>, Snow) reported, “The National Institutes of Health said today that more aggressively lowering target blood pressure would cut the death rate by a staggering 25 percent.”</span></p><p style="text-align: start; margin: 10px 0px 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">In a 1,200-word story on its front page, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=019-146&t=c">New York Times</a>(9/12, A1, Kolata, Subscription Publication) reported that in the study, researchers “randomly assigned more than 9,300 men and women ages 50 and over who were at high risk of heart disease or had kidney disease to one of two systolic blood pressure targets: less than 120 millimeters of mercury, which is lower than any guideline ever suggested, or less than 140.” The researchers “found that patients who were assigned to reach a systolic blood pressure goal below 120 — far lower than current guidelines of 140, and 150 for people over 60 — had their risk of heart attacks, heart failure and strokes reduced by a third and their risk of death reduced by nearly a quarter.”</span></p><p style="text-align: start; margin: 10px 0px 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01a-54d&t=c">AP</a> (9/12, Neergaard) reported that “the benefit was strong enough that NIH stopped the study about a year early.”</span></p><p style="text-align: start; margin: 10px 0px 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01b-7c2&t=c">Wall Street Journal</a> (9/12, A1, Armao, Whalen, Subscription Publication) reported on its front page that during a conference call during which the findings were announced, Dr. Gary H. Gibbons, director of the National Heart, Lung and Blood Institute, said, “More intensive management of high blood pressure in people 50 years and older can save lives and reduce cardiovascular complications, such as heart attacks.” Gibbons added, “This new important information has the potential to benefit a portion of the estimated one in three adults in the United States who suffer from high blood pressure, as well as millions of others worldwide.”</span></p><p style="text-align: start; margin: 10px 0px 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">On its front page, the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01c-69d&t=c">Washington Post</a> (9/12, A1, Bernstein) points out that “the NHBLI was the primary sponsor of the” research. In a statement, Dr. Gibbons said, “This study provides potentially lifesaving information that will be useful to health care providers as they consider the best treatment options for some of their patients, particularly those over the age of 50.”</span></p><p style="text-align: start; margin: 10px 0px 0px;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01d-529&t=c">USA Today</a> (9/12, Szabo) reported, however, that “NIH researchers did not provide any details about how many lives were saved or the side effects of lowering blood pressure so dramatically.”</span></font></p><p style="text-align: start; margin: 10px 0px 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Also covering the story were <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01e-2a8&t=c">Reuters</a> (9/12, Berkrot), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=01f-6ea&t=c">Forbes</a> (9/12, Hedgecock), the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=020-6c6&t=c">NPR</a> (9/12, Stein) “Shots” blog, <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=021-f4a&t=c">Newsweek</a> (9/12, Firger), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=022-731&t=c">CNN</a> (9/12, Capelouto, Goldschmidt), the <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=023-f64&t=c">Huffington Post</a> (9/12), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=024-b32&t=c">TIME</a> (9/12, Luckerson), <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=025-27a&t=c">Medscape</a> (9/12, O'Riordan), and <a href="http://mailview.bulletinhealthcare.com/mailview.aspx?m=2015091401tma&r=7000424-831a&l=026-337&t=c">HealthDay</a>(9/12, Thompson, Reinberg).</span></p><div style="color: rgb(51, 51, 51); font-family: arial, verdana, sans-serif; font-size: 12px; line-height: 18px; -webkit-text-size-adjust: auto;"><br></div></div><a name="prevdayleadstories" style="font-family: arial, verdana, sans-serif; -webkit-text-size-adjust: auto;"></a><span style="font-family: arial, verdana, sans-serif; font-size: medium; -webkit-text-size-adjust: auto; background-color: rgb(255, 255, 255);"></span>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-59493088826233271882015-09-13T09:56:00.001-05:002015-09-13T09:56:42.671-05:00Metformin potentially underused among patients with mild kidney
disease, study finds<div><br></div><div><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">More patients would be eligible for metformin use if estimated glomerular filtration rate (eGFR) were used to define kidney disease rather than serum creatinine (sCr), a recent study concluded.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Researchers used data from the 1999 to 2010 National Health and Nutrition Examination Survey (NHANES) to analyze 3,902 adult participants with diabetes (defined by self-report or an HbA1c ≥6.5%) who reported a routine site for health care. <a target="_blank" href="http://care.diabetesjournals.org/content/early/2015/08/21/dc15-0542.abstract" style="margin: 0px; padding: 0px;">Results</a> were published online on Aug. 25 by <em style="margin: 0px; padding: 0px;">Diabetes Care</em>. </span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Across all 12 years, 66.4% of adults with diabetes were treated with a diabetes medication, and this percentage increased over time, from 61.3% in 1999 to 2000 to 69.7% in 2009 to 2010. Metformin use among those with diabetes and a routine site for health care increased from 26.1% to 44.5%.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Among NHANES adults with diabetes and routine care access, 8.8% were ineligible for metformin because of the FDA's contraindication among individuals with sCr ≥1.4 mg/dL for women and ≥1.5 mg/dL for men. Compared with those who were eligible for the drug, those ineligible were older and more likely to be non-Hispanic black or to have a yearly family income less than $45,000.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Researchers also looked at the patients using (eGFR) categories: likely safe to take metformin, ≥45 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>; contraindicated, <30 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>; and indeterminate, 30 to 44 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>. Evidence has shown eGFR to be a more accurate estimate of kidney function than sCr, the authors noted.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Among individuals ineligible for metformin using conventional sCr thresholds, 14.6% had an eGFR ≥45 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup> and 50% had an eGFR between 30 and 44 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>. Only 35.7% of study participants would be ineligible for metformin based on an eGFR <30 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Based on these results, just by adding those for whom metformin is safe according to eGFR criteria, the researchers estimated the number of individuals eligible for metformin in the U.S. can be expanded by between 86,900 and 834,800 people, depending on which method is used to estimate GFR. Most of the potentially eligible patients are male and non-Hispanic blacks. This figure does not take into account the population with eGFR of indeterminate safety (30 to 44 mL/min/1.73 m<sup style="margin: 0px; padding: 0px;">2</sup>), which could range from 784,700 to 1,636,000 people. A randomized controlled trial is needed to clarify whether metformin use in this subgroup would be safe and efficacious, the authors noted.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Limitations of the study are that NHANES is not a clinical database, although the researchers restricted the study population to those who self-reported a routine site for health care. They also noted that they could not determine the reasoning behind low levels of metformin use, which could include non-renal clinical conditions that contraindicate the use of metformin, such as liver disease.</span></p></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-58514302398221949962015-08-14T12:07:00.001-05:002015-08-14T12:07:46.572-05:00Pioglitazone use not associated with increased risk of bladder cancer,
study finds<p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Pioglitazone was not found to be associated with a statistically significant increased risk of bladder cancer or 8 of 10 additional cancers in a recent study.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">In a large, long-term study, researchers analyzed pioglitazone use and associated risks of the following cancers: bladder, prostate, female breast, lung/bronchus, endometrial, colon, non-Hodgkin lymphoma, pancreas, kidney/renal pelvis, rectum, and melanoma. <a target="_blank" href="http://jama.jamanetwork.com/article.aspx?articleid=2397834" style="margin: 0px; padding: 0px;">Results</a> were published on July 21 by the <em style="margin: 0px; padding: 0px;">Journal of the American Medical Association.</em></span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Of 193,099 people studied, 34,181 (18%) received pioglitazone and 1,261 had incident bladder cancer. Crude incidences of bladder cancer in users and nonusers were 89.8 and 75.9 per 100,000 person-years, respectively, and ever having taken pioglitazone was not associated with bladder cancer risk (adjusted hazard ratio [HR], 1.06; 95% CI, 0.89 to 1.26). However, the study cannot exclude up to a 54% increased risk of bladder cancer, the authors noted.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Use of other diabetes medications, such as metformin, sulfonylureas, insulin, and other thiazolidinediones, was also not significantly associated with bladder cancer risk, with adjusted HRs ranging from 0.91 to 1.09, according to the study.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Although use of pioglitazone was not associated with 8 of 10 additional cancers in adjusted analyses of 236,507 people (HRs ranged from 0.81 to 1.15), use of the medication was associated with increased risk of prostate cancer (HR, 1.13; 95% CI, 1.02 to 1.26) and pancreatic cancer (HR, 1.41; 95% CI, 1.16 to 1.71). Crude incidences of the cancers in pioglitazone users and nonusers were 453.3 versus 449.3 for prostate and 81.1 versus 48.4 for pancreatic per 100,000 person-years. "The increased prostate and pancreatic cancer risks associated with ever use of pioglitazone merit further investigation to assess whether they are causal or are due to chance, residual confounding, or reverse causality," the study authors wrote.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Use of insulin was associated with a decreased risk of prostate cancer (HR, 0.90; 95% CI, 0.81 to 0.99). Use of metformin (HR, 1.21; 95% CI, 1.02 to 1.43), insulin (HR, 2.34; 95% CI, 1.97 to 2.78), and sulfonylureas (HR, 1.49; 95% CI, 1.22 to 1.81) and never having 2 prescriptions of a diabetes medication from the same class within 6 months (HR, 1.55; 95% CI, 1.02 to 2.36) were each associated with increased risk of pancreatic cancer. The fact that other diabetes medications were also associated with an increased risk of pancreatic cancer suggests reverse causality because hyperglycemia is an early manifestation of the cancer, the authors wrote.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The researchers noted that their observational study has potential for unmeasured confounding; has limited statistical power for subgroup analyses related to time since initiation, dose, and duration; and could not exclude all patients with type 1 diabetes (although they minimized this by excluding those under 40).</span></p>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-81719388729680709562015-07-15T23:06:00.001-05:002015-07-15T23:06:17.700-05:00New warnings required for nonaspirin NSAIDs<p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The FDA issued a safety alert last week regarding cardiovascular warnings for nonaspirin NSAIDs.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Prescription NSAIDs have carried warnings about heart attack and stroke risk since 2005. After reviewing new safety information, the FDA decided to strengthen the existing warning and require that all labels for prescription NSAIDs include the following information:</span></p><ul style="margin: 0px 0px 1.2em; padding: 0px;"><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The risk of heart attack or stroke can occur as early as the first weeks of NSAID use; it may increase with longer use and appears to be greater at higher doses.</span></li><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">All NSAIDs were previously thought to have a similar risk for heart attack or stroke. Newer information makes this less clear but is not sufficient for the FDA to determine that any particular NSAID definitely has a higher or lower risk than any other.</span></li><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">NSAIDs can increase the risk of heart attack or stroke in patients with or without heart disease or heart disease risk factors.</span></li><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">In general, patients with heart disease or risk factors for heart disease have a greater likelihood of heart attack or stroke after NSAID use than patients without these risk factors because their baseline risk is higher.</span></li><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Patients treated with NSAIDs after a first heart attack were more likely to die in the first year afterward than those who were not treated with NSAIDs after their first heart attack.</span></li><li style="margin: 0px 0px 0.9em; padding: 0px 0px 0px 10px; list-style-type: none; background-image: url(http://www.acpinternist.org/i/screen/main-marker.gif); background-position: 0px 0.4em; background-repeat: no-repeat no-repeat;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Heart failure risk is increased with NSAID use.</span></li></ul><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The agency is also requesting that these changes be made to the labels of over-the-counter nonaspirin NSAIDs.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The FDA recommended that patients and health care professionals remain alert for heart-related side effects the entire time NSAIDs are taken. Patients who are taking NSAIDs should seek medical attention immediately if they experience such symptoms as chest pain, shortness of breath or trouble breathing, weakness in one part or side of their body, or slurred speech, the FDA said.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The safety alert, which was issued July 9, is available <a target="_blank" href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm454141.htm" style="margin: 0px; padding: 0px;">online</a>. </span></p><div class="addthis_toolbox addthis_default_style" style="margin: 0px; padding: 0px; border: none; float: none; width: auto;"><a class="addthis_button_facebook at300b" id="facebook" addthis:url="http://acpinternist.acponline.org/weekly/archives/2015/7/14/index.html#4" addthis:title="New warnings required for nonaspirin NSAIDs" title="Facebook" href="http://www.acpinternist.org/weekly/archives/2015/7/14/index.html#" style="margin: 0px; padding: 0px 2px; cursor: pointer; float: left; width: auto;"><span class="at4-icon aticon-facebook" style="margin: 0px; padding: 0px; display: block; overflow: hidden; text-indent: -9999em; cursor: pointer; width: 16px; height: 16px; float: left; background-image: url(data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2232%22%20height%3D%2232%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cpath%20fill%3D%22%23fff%22%20d%3D%22M22.439%2010.95h4v-4.95h-4c-3.311%200-6%202.92-6%206.5v2.5h-4v4.97h4v12.03h5v-12.03h5v-4.97h-5v-2.55c0-.86.532-1.5%201-1.5z%22%2F%3E%3C%2Fsvg%3E); background-size: 16px !important; background-position: 0% 50%; background-repeat: no-repeat no-repeat;"><span class="at_a11y" style="text-indent: 0px; margin: 0px; padding: 0px; position: absolute !important; top: auto !important; width: 1px !important; height: 1px !important; overflow: hidden !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Share on facebook</span></font></span></span></a><a class="addthis_button_twitter at300b" id="twitter" addthis:url="http://acpinternist.acponline.org/weekly/archives/2015/7/14/index.html#4" addthis:title="New warnings required for nonaspirin NSAIDs" title="Tweet" href="http://www.acpinternist.org/weekly/archives/2015/7/14/index.html#" style="margin: 0px; padding: 0px 2px; cursor: pointer; float: left; width: auto;"><span class="at4-icon aticon-twitter" style="margin: 0px; padding: 0px; display: block; overflow: hidden; text-indent: -9999em; cursor: pointer; width: 16px; height: 16px; float: left; background-image: url(data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2232%22%20height%3D%2232%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cpath%20fill%3D%22%23fff%22%20d%3D%22M26.67%209.38c-.779.35-1.63.58-2.51.69.9-.54%201.6-1.4%201.92-2.42-.85.5-1.78.87-2.78%201.06-.8-.85-1.94-1.38-3.19-1.38-2.42%200-4.379%201.96-4.379%204.38%200%20.34.04.68.11%201-3.64-.18-6.86-1.93-9.02-4.57-.38.65-.59%201.4-.59%202.2%200%201.52.77%202.86%201.95%203.64-.72-.02-1.39-.22-1.98-.55v.06c0%202.12%201.51%203.89%203.51%204.29-.37.1-.75.149-1.15.149-.28%200-.56-.029-.82-.08.56%201.74%202.17%203%204.09%203.041-1.5%201.17-3.39%201.869-5.44%201.869-.35%200-.7-.02-1.04-.06%201.94%201.239%204.24%201.97%206.71%201.97%208.049%200%2012.45-6.67%2012.45-12.45l-.01-.57c.839-.619%201.579-1.389%202.169-2.269z%22%2F%3E%3C%2Fsvg%3E); background-size: 16px !important; background-position: 0% 50%; background-repeat: no-repeat no-repeat;"><span class="at_a11y" style="text-indent: 0px; margin: 0px; padding: 0px; position: absolute !important; top: auto !important; width: 1px !important; height: 1px !important; overflow: hidden !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Share on twitter</span></font></span></span></a><a class="addthis_button_linkedin at300b" id="linkedin" addthis:url="http://acpinternist.acponline.org/weekly/archives/2015/7/14/index.html#4" addthis:title="New warnings required for nonaspirin NSAIDs" target="_blank" title="LinkedIn" href="http://www.acpinternist.org/weekly/archives/2015/7/14/index.html#" style="margin: 0px; padding: 0px 2px; cursor: pointer; float: left; width: auto;"><span class="at4-icon aticon-linkedin" style="margin: 0px; padding: 0px; display: block; overflow: hidden; text-indent: -9999em; cursor: pointer; width: 16px; height: 16px; float: left; background-image: url(data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2232%22%20height%3D%2232%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cpath%20fill%3D%22%23fff%22%20d%3D%22M8%2012h4v14h-4zM23.27%2012.8c-1.49-.84-3.689-.91-5.27-.18v-.62h-4v14h4v-8.95l1.65-.79c.399-.19%201.289-.18%201.66.03.29.15.69.81.69%201.21v8.5h4v-8.5c0-1.84-1.15-3.82-2.73-4.7z%22%2F%3E%3Ccircle%20fill%3D%22%23fff%22%20cx%3D%2210%22%20cy%3D%228%22%20r%3D%222.5%22%2F%3E%3C%2Fsvg%3E); background-size: 16px !important; background-position: 0% 50%; background-repeat: no-repeat no-repeat;"><span class="at_a11y" style="text-indent: 0px; margin: 0px; padding: 0px; position: absolute !important; top: auto !important; width: 1px !important; height: 1px !important; overflow: hidden !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Share on linkedin</span></font></span></span></a><a class="addthis_button_email at300b" id="email" addthis:url="http://acpinternist.acponline.org/weekly/archives/2015/7/14/index.html#4" addthis:title="New warnings required for nonaspirin NSAIDs" target="_blank" title="Email" href="http://www.acpinternist.org/weekly/archives/2015/7/14/index.html#" style="margin: 0px; padding: 0px 2px; cursor: pointer; float: left; width: auto;"><span class="at4-icon aticon-email" style="margin: 0px; padding: 0px; display: block; overflow: hidden; text-indent: -9999em; cursor: pointer; width: 16px; height: 16px; float: left; background-image: url(data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20width%3D%2232%22%20height%3D%2232%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cpath%20fill%3D%22%23fff%22%20d%3D%22M26.189%209.55h-20.149l10.02%207.57%2010.129-7.57zm-10.129%2010.12l-10.28-8.8v11.58h20.57v-11.49l-10.29%208.71z%22%2F%3E%3C%2Fsvg%3E); background-size: 16px !important; background-position: 0% 50%; background-repeat: no-repeat no-repeat;"><span class="at_a11y" style="text-indent: 0px; margin: 0px; padding: 0px; position: absolute !important; top: auto !important; width: 1px !important; height: 1px !important; overflow: hidden !important;"><font color="#000000"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Share on ema</span></font></span></span></a></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-85074107377161367192015-06-02T00:41:00.001-05:002015-06-02T00:41:09.066-05:00ACE inhibitors, ARBs most effective against ESRD in patients with
diabetes, kidney disease<p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) appear most effective in preventing end-stage renal disease (ESRD) in patients with diabetes and kidney disease, although no regimen to lower blood pressure seems to prolong survival, a recent analysis has found.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Researchers performed a network meta-analysis of randomized trials comparing the effects of oral blood pressure-lowering agents in adults who had diabetic kidney disease. The primary outcomes were all-cause mortality and ESRD; secondary safety and cardiovascular outcomes were also assessed. All drug regimens were ranked comparatively against placebo. The study <a target="_blank" href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2962459-4/abstract" style="margin: 0px; padding: 0px;">results</a> were published online on May 23 by <em style="margin: 0px; padding: 0px;">The Lancet</em>. </span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Overall, 157 studies involving 43,256 patients were included in the meta-analysis. The mean patient age was 52.5 years. The drug classes compared with placebo or standard treatment were ACE inhibitors, ARBs, aldosterone antagonists, beta-blockers, calcium-channel blockers, endothelin inhibitors, and renin inhibitors. None of the drug regimens examined appeared to be more effective in reducing all-cause mortality. ESRD was significantly less likely in patients treated with an ARB and an ACE inhibitor (odds ratio, 0.62; 95% CI, 0.43 to 0.90) and in those treated with only an ARB (odds ratio, 0.77; 95% CI, 0.65 to 0.92) versus those treated with placebo.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Hyperkalemia and acute kidney injury did not appear to increase significantly with any regimen (calcium-channel blocker, beta-blocker, ACE inhibitor plus diuretic, endothelin inhibitor, diuretic, renin inhibitor, ARB, ACE inhibitor, aldosterone antagonist, and ACE inhibitor plus ARB for hyperkalemia; ACE inhibitor plus calcium-channel blocker, calcium-channel blocker, ACE inhibitor, renin inhibitor, endothelin inhibitor, ARB, aldosterone antagonist, and ACE inhibitor plus ARB for acute kidney injury). However, the authors noted that ACE inhibitor plus ARB was the regimen with the highest odds ratios for these 2 outcomes (odds ratios, 2.69 [95% CI, 0.97 to 7.47] and 2.69 [95% CI, 0.98 to 7.38]).</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The authors noted that their study had limited primary data, that data for the ESRD outcome came mainly from patients with macroalbuminuria and patients with type 2 diabetes, and that acute kidney injury was not well defined, among other limitations. They concluded that based on available evidence, lowering blood pressure in adults with diabetes and kidney disease does not appear to improve survival but that ACE inhibitors and ARBs, together or alone, appear most effective in preventing ESRD in this population.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">"However, we must consider the potential harms of these treatments in individual patients," the authors wrote. "Surveillance for treatment-related acute kidney injury and hyperkalaemia is important, as is better standardisation of the definitions of these adverse events and improved understanding of their outcomes, particularly in the context of future trials." They also noted that their results don't support the use of beta-blockers, calcium-channel blockers, renin inhibitors, or diuretic monotherapy in this patient population.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The authors of an accompanying comment said that the results "reignite the debate" about the utility of dual renin-angiotensin-aldosterone system (RAAS) blockade and said that the findings will help researchers design future trials examining this question. The comment authors pointed out that preventive treatments for end-stage kidney failure are urgently needed in diabetic patients.</span></p><p style="margin: 0px 0px 1.2em; padding: 0px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">"Screening for albuminuria and prompt initiation of lifestyle and pharmacological interventions is likely to prevent progression of chronic kidney disease and cardiovascular disease," they <a target="_blank" href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2960132-5/abstract" style="margin: 0px; padding: 0px;">wrote</a>. "Addition of dual ACE inhibitor and ARB treatment to this multifactorial management approach—if confirmed to be efficacious and cost effective—might further improve patients' outcomes in regions of the world where careful selection of patients and close monitoring are possible."</span></p>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0tag:blogger.com,1999:blog-1619592806979659394.post-919071410249422382015-05-16T07:27:00.001-05:002015-05-16T07:27:07.026-05:00Power Down in May for National High Blood Pressure Education Monthhttp://www.cdc.gov/Features/HighBloodPressure/<div><br></div><div><div class="syndicate"><div class="mSyndicate"><p style="margin: 0px 0px 10px;"><img class="pull-right img-polaroid margin-left-ten" alt="Photo: Doctor taking woman's blood pressure" src="http://www.cdc.gov/features/highbloodpressure/highbloodpressure_456px.jpg" style="max-width: 100%; height: auto; vertical-align: middle; border: 1px solid rgba(0, 0, 0, 0.2); padding: 4px; -webkit-box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; float: right; margin-left: 10px !important;"><span style="font-weight: 700; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Reducing high blood pressure can lower your risk for stroke and heart attack.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Less is better in some things, including in blood pressure. About 1 of 3 US adults—67 million people—have high blood pressure.<span style="position: relative; vertical-align: baseline; top: -0.5em;">1</span>High blood pressure makes your heart work too hard and increases your risk of heart disease and stroke.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">You can have high blood pressure and not know it. That is why it is called the silent killer. It is also why it is so important to have your blood pressure checked. If you know family or friends who haven't had their blood pressure checked recently, make it a point to ask them to do it in May, National High Blood Pressure Education Month.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">It is easy to check blood pressure and it is painless. It can be checked by your doctor, and many pharmacies have free screenings.</span></p><h3 style="margin: 10px 0px; font-weight: 400; text-rendering: optimizelegibility;"><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Caution! Arteries Under Pressure</span></h3><span style="max-width: 100%; height: auto; vertical-align: middle; border: 1px solid rgba(0, 0, 0, 0.2); padding: 4px; -webkit-box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; float: right; margin-left: 10px !important;"><img class="pull-right img-polaroid margin-left-ten" alt="Photo: Senior man by swimming pool" src="http://www.cdc.gov/features/highbloodpressure/highbloodpressure_a200px.jpg" style="max-width: 100%; height: auto; vertical-align: middle; border: 1px solid rgba(0, 0, 0, 0.2); padding: 4px; -webkit-box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; float: right; margin-left: 10px !important;"></span><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Blood pressure is the force of blood on the walls of your blood vessels as blood flows through them. This pressure naturally rises and falls during the day, but when it is consistently too high, it is considered high blood pressure. The medical term is hypertension.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Like the pipes in your house, your arteries can fail if they are under too much pressure. The video, "High Blood Pressure Basics," illustrates the concept of high blood pressure.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">More than 360,000 American deaths in 2010 included high blood pressure as a primary or contributing cause.<span style="position: relative; vertical-align: baseline; top: -0.5em;">2</span> That's 1,000 deaths each day.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Blood pressure has two numbers, systolic and diastolic, and is measured in millimeters of mercury (mmHg). Systolic pressure (the top number) is the force on the blood vessel walls when the heart beats and pumps blood out of the heart. Diastolic pressure (the bottom number) is the force that occurs when the heart relaxes in between beats.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">If your blood pressure is less than 120 systolic and less than 80 diastolic, then your blood pressure is normal; between 120 and 139 systolic and 80–89 diastolic, you have prehypertension. Systolic of 140 or greater, or diastolic that is 90 or greater, is hypertension.</span></p><h3 style="margin: 10px 0px; font-weight: 400; text-rendering: optimizelegibility;"><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">What Is Your Risk?</span></h3><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Men and women are about equally likely to develop high blood pressure over their lifetimes, but their risks vary at different ages. The condition affects more men than women before 64 years of age. For people aged 65 years or older, more women than men have high blood pressure.</span></p><table border="1" cellpadding="2" cellspacing="0" width="100%" style="max-width: 100%; border-collapse: collapse; border-spacing: 0px;"><tbody><tr><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Age</span></p></th><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Men (%)</span></p></th><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Women (%)</span></p></th></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">20–34</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">9.1</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">6.7</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">35–44</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">24.4</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">17.6</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">45–54</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">37.7</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">37.7</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">55–64</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">52.0</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">52.0</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">65–74</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">63.9</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">70.8</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">75+</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">72.1</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">80.1</span></td></tr></tbody></table><p style="margin: 0px 0px 10px;"><em style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Data in this table are from the 2014 AHA Statistical Update, using 2007-2010 NHANES</em></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">African Americans develop high blood pressure more often, and at an earlier age, than whites and Hispanics do. More black women than men have high blood pressure.<span style="position: relative; vertical-align: baseline; top: -0.5em;">3</span></span></p><table border="1" cellpadding="2" cellspacing="0" width="100%" style="max-width: 100%; border-collapse: collapse; border-spacing: 0px;"><tbody><tr><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Racial or Ethnic Group</span></p></th><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Men (%)</span></p></th><th><p style="margin: 0px 0px 10px; font-weight: 400;"><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Women (%)</span></p></th></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Blacks</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">40.5</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">44.3</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Mexican Americans</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">28.6</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">27.8</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Whites</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">31.1</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">28.1</span></td></tr><tr><td><span style="font-weight: 700; font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">All</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">31.3</span></td><td><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">29.6</span></td></tr></tbody></table><p style="margin: 0px 0px 10px;"><em style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Data in this table are from Health US 2012, using 2007-2010 NHANES</em></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">African American men are disproportionately affected by cardiovascular disease (CVD). One of the reasons for this has to do with the rates of uncontrolled high blood pressure among African American men. Uncontrolled high blood pressure among African American men aged 20 years and older is 59.7%; compared to 47.0% of white men. Uncontrolled hypertension among African American women is 47.3% compared to 43.2% for white women.<span style="position: relative; vertical-align: baseline; top: -0.5em;">2</span></span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Eliminating health disparities among various segments of the population is a CDC priority and a Healthy People 2010 goal.</span></p><h3 style="margin: 10px 0px; font-weight: 400; text-rendering: optimizelegibility;"><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Keep It Down in There!</span></h3><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">If you have high blood pressure, there are steps you can take to get it under control, including—</span></p><ul style="padding: 0px; margin: 0px 0px 10px 25px;"><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="font-weight: 700;">Ask your doctor what your blood pressure should be.</span>Set a goal to lower your pressure with your doctor and then discuss how you can reach your goal. Work with your health care team to make sure you meet that goal.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="font-weight: 700;">Take your blood pressure medication as directed.</span> If you are having trouble, ask your doctor what you can do to make it easier. For example, you may want to discuss your medication schedule with your doctor if you are taking multiple drugs at different times of the day. Or you may want to discuss side effects you are feeling, or the cost of your medicine.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="font-weight: 700;">Quit smoking—and if you don't smoke, don't start.</span>You can find tips and resources at CDC's Smoking and Tobacco Web site or Be Tobacco Free Web site.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="font-weight: 700;">Reduce sodium.</span> Most Americans consume too much sodium, and it raises blood pressure in most people. Learn about tips to reduce your sodium.</span></li></ul><p style="margin: 0px 0px 10px;"><img class="pull-right img-polaroid margin-left-ten" alt="Photo: Two women riding bicycles" src="http://www.cdc.gov/features/highbloodpressure/highbloodpressure_b200px.jpg" style="max-width: 100%; height: auto; vertical-align: middle; border: 1px solid rgba(0, 0, 0, 0.2); padding: 4px; -webkit-box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; box-shadow: rgba(0, 0, 0, 0.0980392) 0px 1px 3px; float: right; margin-left: 10px !important;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">There are other healthy habits, that can help keep your blood pressure under control—</span></p><ul style="padding: 0px; margin: 0px 0px 10px 25px;"><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Achieve and maintain a healthy body weight.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Participate in 30 minutes of moderate physical activity on most days of the week.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Eat a healthy diet that is high in fruits and vegetables and low in sodium, saturated fats, trans fat, and cholesterol.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Manage stress.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Limit the amount of alcohol you drink (no more than one drink each day for women and two for men).</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">If you have high blood pressure and are prescribed medication, take it as directed.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">If you have a family member who has high blood pressure, you can help by taking many of the steps listed above with them. Go for walks together or cook meals with lower sodium. Make it a family affair!</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Check your blood pressure regularly.</span></li></ul><h3 style="margin: 10px 0px; font-weight: 400; text-rendering: optimizelegibility;"><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Resources</span></h3><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">The <span style="font-weight: 700;">Dietary Approaches to Stop Hypertension</span> (DASH) can help control high blood pressure through a healthy diet.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">"I can do it!" is the message of the <span style="font-weight: 700;">My Blood Pressure Wallet Card</span> that helps patients monitor their blood pressure readings, remember to take their medications, and keep up the lifestyle changes that will help lower their blood pressure.</span></p><p style="margin: 0px 0px 10px;"><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);"><span style="font-weight: 700;">Million Hearts®</span> is a national initiative to prevent 1 million heart attacks and strokes in the United States by 2017. Launched by the US Department of Health and Human Services (HHS), it aligns existing efforts and creates new programs to help Americans live longer, more productive lives. The CDC and Centers for Medicare and Medicaid Services, co-leaders of Million Hearts™ within HHS, are working alongside other federal agencies and private-sector organizations to make a long-lasting impact against cardiovascular disease.</span></p></div></div><div class="row" style="margin-left: 0px;"><div class="span19" style="float: none; min-height: 1px; margin-left: 0px; width: 398px; box-sizing: border-box; clear: right;"><div class="module-typeA" style="margin-bottom: 10px; box-sizing: border-box; padding-bottom: 10px; overflow: hidden; border: 1px solid rgb(229, 229, 229);"><h3 style="margin: 0px 0px 10px; font-weight: 400; text-rendering: optimizelegibility; padding: 5px 10px; border-bottom-width: 1px; border-bottom-color: rgb(229, 229, 229); border-bottom-style: solid;"><span style="font-size: 17px; -webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">References</span></h3><ol class="list-bullet" style="padding: 0px 15px; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 35px !important;"><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">CDC. Vital signs: awareness and treatment of uncontrolled hypertension among adults—United States, 2003–2010. <em>MMWR</em>. 2012;61:703-9.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. <em>Circulation.</em>2014;129:e28-e292.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">CDC. <em>Health, United States, 2012: With Special Feature on Emergency Care.</em> Atlanta, GA: US Department of Health and Human Services; 2013.</span></li><li><span style="-webkit-text-size-adjust: auto; background-color: rgba(255, 255, 255, 0);">CDC. <em>A Closer Look at African American Men and High Blood Pressure Control: A Review of Psychosocial Factors and Systems-Level Interventions.</em> Atlanta, GA: US Department of Health and Human Services; 2010.</span></li></ol></div></div></div></div>Anonymoushttp://www.blogger.com/profile/09207817565720466414noreply@blogger.com0